By Adria Calatayud MorphoSys shares jumped after the German biotechnology company agreed to be taken over by Swiss pharmaceutical giant Novartis in an.
By Adria Calatayud Novartis reported a big jump in fourth-quarter net profit after it booked a gain from the spinoff of its generics-drugs business Sandoz..
By Adria Calatayud Novartis reported a big jump in fourth-quarter net profit after it booked a gain from the spinoff of its generics-drugs business Sandoz..
By Adria Calatayud Novartis shares dropped after the Swiss pharmaceutical giant reported fourth-quarter earnings and sales that missed consensus expectations.
By Adria Calatayud Novartis is scheduled to report results for the fourth quarter on Wednesday. Here is what you need to know. SALES FORECAST: The Swiss.